Constantinescu S N, Croze E, Murti A, Wang C, Basu L, Hollander D, Russell-Harde D, Betts M, Garcia-Martinez V, Mullersman J E, Pfeffer L M
Department of Pathology (576 BMH), University of Tennessee Health Science Center, Memphis 38163, USA.
Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10487-91. doi: 10.1073/pnas.92.23.10487.
The IFNAR chain of the type I interferon (IFN) receptor (IFNIR) undergoes rapid ligand-dependent tyrosine phosphorylation and acts as a species-specific transducer for type I IFN action. Using the vaccinia/T7 expression system to amplify IFNAR expression, we found that human HeLa-S3 cells transiently express high levels of cell surface IFNAR chains (approximately 250,000 chains per cell). Metabolic labeling and immunoblot analysis of transfected HeLa cells show that the IFNAR chain is initially detected as 65-kDa and 98-kDa precursors, and then as the 130-kDa mature protein. Due to variation in N-glycosylation, the apparent molecular mass of the mature IFNAR chain varies from 105 to 135 kDa in different cells. IFNIR structure was characterized in various human cell lines by analyzing 125I-labeled IFN cross-linked complexes recognized by various antibodies against IFNIR subunits and JAK protein-tyrosine kinases. Precipitation of cross-linked material from Daudi cells with anti-IFNAR antibodies showed that IFNAR was present in a 240-kDa complex. Precipitation of cross-linked material from U937 cells with anti-TYK2 sera revealed a 240-kDa complex, which apparently did not contain IFNAR and was not present in IFN-resistant HEC1B cells. The tyrosine phosphorylation and down-regulation of the IFNAR chain were induced by type I IFN in several human cell lines of diverse origins but not in HEC1B cells. However, of type I IFNs, IFN-beta uniquely induced the tyrosine phosphorylation of a 105-kDa protein associated with the IFNAR chain in two lymphoblastoid cell lines (Daudi and U266), demonstrating the specificity of transmembrane signaling for IFN-beta and IFN-alpha through the IFNAR chain.
I型干扰素(IFN)受体(IFNIR)的IFNAR链会经历快速的配体依赖性酪氨酸磷酸化,并作为I型IFN作用的物种特异性转导器。利用痘苗病毒/T7表达系统来扩增IFNAR的表达,我们发现人HeLa-S3细胞短暂表达高水平的细胞表面IFNAR链(约每细胞250,000条链)。对转染的HeLa细胞进行代谢标记和免疫印迹分析表明,IFNAR链最初被检测为65 kDa和98 kDa的前体,然后是130 kDa的成熟蛋白。由于N-糖基化的差异,成熟IFNAR链在不同细胞中的表观分子量在105至135 kDa之间变化。通过分析针对IFNIR亚基和JAK蛋白酪氨酸激酶的各种抗体识别的125I标记的IFN交联复合物,对多种人类细胞系中的IFNIR结构进行了表征。用抗IFNAR抗体从Daudi细胞中沉淀交联物质表明,IFNAR存在于240 kDa的复合物中。用抗TYK2血清从U937细胞中沉淀交联物质揭示了一个240 kDa的复合物,该复合物显然不包含IFNAR,并且不存在于对IFN耐药的HEC1B细胞中。I型IFN在多种来源的几种人类细胞系中诱导IFNAR链的酪氨酸磷酸化和下调,但在HEC1B细胞中不诱导。然而,在I型IFN中,IFN-β在两种淋巴母细胞系(Daudi和U266)中独特地诱导了与IFNAR链相关的105 kDa蛋白的酪氨酸磷酸化,证明了通过IFNAR链进行跨膜信号传导对IFN-β和IFN-α的特异性。